{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/palliative-care-nausea-vomiting/management/unknown-cause/","result":{"pageContext":{"chapter":{"id":"c8237819-4755-5cd8-ad7c-12735068c87a","slug":"unknown-cause","fullItemName":"Scenario: Unknown cause","depth":2,"htmlHeader":"<!-- begin field f8b00e28-1f73-47b6-9a76-6e53dfff71bc --><h2>Scenario: Unknown cause</h2><!-- end field f8b00e28-1f73-47b6-9a76-6e53dfff71bc -->","summary":"Covers management of nausea and vomiting in palliative care when the cause is not known. This scenario also covers treatment options when first-line anti-emetics have not worked.","htmlStringContent":"<!-- begin item 411499fe-f9c3-47ad-a2c6-f4ca7ea734cc --><!-- begin field 1b0d6157-e08e-4a30-ae35-acbc015bbb3b --><p>From age 16 years onwards.</p><!-- end field 1b0d6157-e08e-4a30-ae35-acbc015bbb3b --><!-- end item 411499fe-f9c3-47ad-a2c6-f4ca7ea734cc -->","topic":{"id":"8a2e6dd8-7d6f-5fcf-a744-1b12e2a14232","topicId":"329a162f-132a-4d7e-afd5-7ff2f86369d2","topicName":"Palliative care - nausea and vomiting","slug":"palliative-care-nausea-vomiting","lastRevised":"Last revised in October 2020","chapters":[{"id":"4cf6ed2e-fa29-54e9-8d93-4bd52407c5c4","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"2e3a3e75-af78-5547-a042-7aa68a341672","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"27d24f4a-dbc8-560f-b100-ca5287022d66","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"b433057a-92f0-5457-837c-f3f7235e44e6","slug":"changes","fullItemName":"Changes"},{"id":"540b41fe-3e71-5c29-9379-7493711a8a59","slug":"update","fullItemName":"Update"}]},{"id":"ed201382-7c29-58e9-ba5d-f5c415eb3bf3","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"7043600f-13dd-5980-b06d-73dab2266896","slug":"goals","fullItemName":"Goals"},{"id":"63b87fa3-3c3d-527b-9ac2-e856dd0c559e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"6e3ee330-3c0d-5735-b8d5-76b606865d07","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d1227949-2a90-5b29-abef-3895e05333c3","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e2e036e5-217a-593d-947f-a8376f0f5e98","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"3885ba7b-9d6f-5262-a541-463284363660","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b65bec71-2fa0-54e0-be57-13a917c2a697","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a9561403-d5a9-5c9c-b6e6-c24410e9d9d3","slug":"definition","fullItemName":"Definition"},{"id":"d92b4aee-031c-58a4-b4b9-5d13767e0261","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b1327253-7b93-5a44-b2f7-5e002ae90e8f","slug":"causes","fullItemName":"Causes"},{"id":"e321f36e-5ec2-5074-b128-109efef69a65","slug":"complications","fullItemName":"Complications"}]},{"id":"a4a81f08-7894-5ba4-a4e5-c5505f3e5250","fullItemName":"Management","slug":"management","subChapters":[{"id":"8691c12d-3ed6-5e16-bef3-667d198f6707","slug":"assessment","fullItemName":"Scenario: Assessment"},{"id":"e2566bf0-9d82-5bc7-9b5f-835384f56bc2","slug":"known-cause","fullItemName":"Scenario: Known cause"},{"id":"c8237819-4755-5cd8-ad7c-12735068c87a","slug":"unknown-cause","fullItemName":"Scenario: Unknown cause"},{"id":"145fe4aa-682c-5299-9906-a7bca2e98a9b","slug":"end-of-life","fullItemName":"Scenario: End of life"}]},{"id":"4d9745dc-8b36-500d-8e94-0e51611a4373","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"f61e929d-def9-58db-877e-a030bc91d3de","slug":"prescribing-an-anti-emetic","fullItemName":"Prescribing an anti-emetic"},{"id":"d39c4487-f9dc-5d1d-be98-95561ca991bd","slug":"prescribing-a-prokinetic","fullItemName":"Prescribing a prokinetic"},{"id":"23e74db2-9671-539b-8bcf-b5c4bdff23f9","slug":"prescribing-haloperidol","fullItemName":"Prescribing haloperidol"},{"id":"00a2a0a3-8bc1-5d27-a03f-6cd4624d1c38","slug":"prescribing-levomepromazine","fullItemName":"Prescribing levomepromazine"},{"id":"d0437d3a-566f-5df2-9800-1961ed4664e8","slug":"prescribing-cyclizine","fullItemName":"Prescribing cyclizine"},{"id":"e6d5c2a8-e2b8-55c5-afd4-46f2edcd4a30","slug":"prescribing-dexamethasone","fullItemName":"Prescribing dexamethasone"},{"id":"3042d096-a74b-5c66-8d18-8c233091e783","slug":"prescribing-hyoscine-butylbromide","fullItemName":"Prescribing hyoscine butylbromide"}]},{"id":"ba414d8a-38a1-5962-84ab-6051ffe6dfe9","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"26e42d0a-9ee9-50c5-9f2b-818da289f6e9","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c0795c41-1865-5ab1-b820-e41b8b5d9aab","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"3076afc1-a703-524e-9ec9-995b34c4d386","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"08b8fc57-db22-518d-a528-777cb4e8d7dc","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"81928ac1-4f26-5da9-b11f-85d1cee4fbdd","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"5aee10d5-2771-547a-a52a-1fb430319da3","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3cfa53b2-3d63-508d-80ea-c2a6293844fc","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"a4a81f08-7894-5ba4-a4e5-c5505f3e5250","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"bf275d81-2b58-5c2f-bc38-192e21b7ba44","slug":"simple-measures","fullItemName":"Simple measures","depth":3,"htmlHeader":"<!-- begin field 5bd27582-b004-4948-944e-de37393cab85 --><h3>What simple measures may help nausea and vomiting in palliative care?</h3><!-- end field 5bd27582-b004-4948-944e-de37393cab85 -->","summary":null,"htmlStringContent":"<!-- begin item 2df95567-a1f4-47f8-ba48-b754988b74c6 --><!-- begin field 6923bcfd-2751-416f-a8e5-dac271b5c0cb --><ul><li>Make sure the person has access to a large bowl, tissues, and water.</li><li>The sight and smell of food or drink may provoke nausea:<ul><li>Provide a calm environment away from where food is usually prepared or consumed.</li><li>If the person is usually responsible for cooking, make alternative arrangements.</li><li>Make sure that meals are small and palatable — snacks consisting of a few mouthfuls are less challenging than big meals.</li><li>Carbohydrate meals are often better tolerated.</li><li>Offer cool, fizzy drinks (citrus flavours are often preferred) — these are more palatable than still or hot drinks.</li></ul></li><li>Consider parenteral hydration, if appropriate (in all people but those at the very end of life). Parenteral hydration, 500–1000 mL/24 hours, may help to reduce persistent nausea.</li><li>Consider the use of complementary therapies; relaxation and acupressure bands may be useful to relieve symptoms.</li><li>Consider cognitive behavioural therapy for anticipatory nausea or vomiting.</li><li>In general, avoid nasogastric suction. It has no role in the management of most causes of nausea and vomiting.</li></ul><!-- end field 6923bcfd-2751-416f-a8e5-dac271b5c0cb --><!-- end item 2df95567-a1f4-47f8-ba48-b754988b74c6 -->","subChapters":[{"id":"181624eb-96ce-5fdb-9d63-b362c867f829","slug":"basis-for-recommendation-6aa","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field fbc28c13-1a35-48f8-9a3e-61c10e9c348a --><h4>Basis for recommendation</h4><!-- end field fbc28c13-1a35-48f8-9a3e-61c10e9c348a -->","summary":null,"htmlStringContent":"<!-- begin item 6aa906d1-9d2f-463e-8b0a-8e0171f0f616 --><!-- begin field 8c8dc843-403c-4a50-b220-10ad9dcc0cda --><p>These recommendations are based on palliative care literature from textbooks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Twycross et al, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Hardy, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Regnard, 2010</a>] and published journal articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Wright, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Mannix, 2006</a>].</p><ul><li>Evidence from a small observational study (n = 54) of hospice patients suggested that acupressure has benefit in controlling nausea and vomiting [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Wright, 2005</a>]. Although the study had methodological weaknesses which limit the findings, the risk of this technique is probably low; acupressure bands are safe and easy to administer [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Ernst et al, 2006</a>].</li><li>CKS could not find studies relating to acupuncture or relaxation for people experiencing nausea and vomiting in general palliative care; the trials and reviews that were found related to chemotherapy-related nausea and vomiting (treatment of which is not covered in this CKS topic) and people experiencing nausea and vomiting who were not receiving palliative care (for example motion sickness, pregnancy, post-operative).<ul><li>A review provides positive evidence that relaxation is effective for preventing nausea before, during, and after chemotherapy and is usually a low-risk intervention [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Ernst et al, 2006</a>]. In view of this, CKS extrapolated this evidence to recommend consideration of relaxation therapies for people receiving palliative care, since this may provide benefit with little chance of harm.</li><li>A paper written by a consultant in palliative care medicine suggests that although studies in the palliative care setting are lacking, case reports suggest that acupuncture can be helpful [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Mannix, 2006</a>]. In the absence of stronger evidence relating to the general palliative care population and considering the potential (albeit rare) adverse effects of acupuncture, CKS could not extrapolate this tentatively positive evidence on acupuncture for chemotherapy-induced nausea [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Ernst et al, 2006</a>] to make a recommendation.</li></ul></li><li>Expert opinion in a textbook suggests that nasogastric suction has no role in the management of most causes of nausea and vomiting but may be useful in [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Regnard, 2010</a>]:<ul><li>Gastric outflow or duodenal obstruction — to reduce high volume of vomiting.</li><li>Gastric atony ('floppy stomach') — a nasogastric tube can be passed easily and removed after all the fluid and air has been aspirated.</li><li>Faecal vomiting.</li></ul></li></ul><!-- end field 8c8dc843-403c-4a50-b220-10ad9dcc0cda --><!-- end item 6aa906d1-9d2f-463e-8b0a-8e0171f0f616 -->","subChapters":[]}]},{"id":"4c1869ff-6353-5c18-8337-207cebad5bcb","slug":"managing-unknown-cause","fullItemName":"Managing unknown cause","depth":3,"htmlHeader":"<!-- begin field 26cc3075-6dd7-4e8c-81cc-7be404e4af37 --><h3>Managing unknown cause</h3><!-- end field 26cc3075-6dd7-4e8c-81cc-7be404e4af37 -->","summary":null,"htmlStringContent":"<!-- begin item 23d76db9-03da-4c27-8543-06763c462958 --><!-- begin field 3867b8d3-d1b8-4c12-bfa6-fb683a5a8a71 --><ul><li>Try <a class=\"topic-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/management/unknown-cause/#simple-measures\">simple measures</a> to relieve symptoms.</li><li>Review the person's history, examination results, and medication(s), and consider checking blood for signs of renal failure, hypercalcaemia, liver failure, or blood glucose abnormalities.</li><li>If the cause is still uncertain or further investigation is not appropriate:<ul><li>Try haloperidol.<ul><li>Usual oral dose: 1.5 mg at night or twice daily and titrate up to a maximum of 10 mg daily (some experts suggest a lower starting dose of 0.5 mg).</li><li>As-required dose: oral, 1.5 mg; subcutaneous injection,1.25–2.5 mg.</li><li>Syringe driver dose per 24 hours: 2.5–10 mg.</li></ul></li><li>If haloperidol alone is not effective, add cyclizine.<ul><li>Usual oral dose: 25–50 mg every 8 hours up to a maximum dose of 150 mg daily.</li><li>As-required dose for oral and subcutaneous injection:1.5 mg.</li><li>Syringe driver dose per 24 hours: 50–150 mg.</li></ul></li><li>If still ineffective, change to levomepromazine or consider a trial of dexamethasone (seek specialist advice first).</li></ul></li><li>Ascertain the most appropriate route of administration of the anti-emetic(s).</li><li>Prescribe anti-emetics regularly <em>and </em>as required.</li><li>Review the effectiveness of anti-emetic treatment every 24 hours.</li><li>Continue anti-emetics unless nausea and vomiting has resolved.</li></ul><!-- end field 3867b8d3-d1b8-4c12-bfa6-fb683a5a8a71 --><!-- end item 23d76db9-03da-4c27-8543-06763c462958 -->","subChapters":[{"id":"fe15b32d-6d87-5e6a-9f1b-efab64d3316c","slug":"basis-for-recommendation-d96","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field e1356740-d35f-48dd-ad40-acc58c464777 --><h4>Basis for recommendation</h4><!-- end field e1356740-d35f-48dd-ad40-acc58c464777 -->","summary":null,"htmlStringContent":"<!-- begin item d960077e-0630-4df1-ade2-19591c792d3a --><!-- begin field 11ef7941-2a41-4317-9e20-604f27165d59 --><p>These recommendations are consistent with specialist palliative care guidelines for the management of nausea and vomiting [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">NHS Scotland, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Lothian Palliative Care Guidelines Group, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Northern England Clinical Networks, 2016</a>] and on palliative care literature from textbooks [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Regnard, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Twycross, 2014</a>].</p><ul><li>With appropriate history, examination, and investigation (where appropriate) it is unusual not to have some indication of the cause of the nausea and vomiting. Specialist palliative care guidelines for the management of nausea and vomiting recommend levomepromazine as the anti-emetic of choice for nausea and vomiting of unknown or multiple causes because of its broad spectrum of activity [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">NHS Scotland, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Lothian Palliative Care Guidelines Group, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Regnard, 2010</a>].</li><li>CKS expert reviewers, however, consider levomepromazine too sedating to be recommended as first choice. An initial trial of haloperidol is recommended because the unknown causes are often metabolic, biochemical, or drug-related.</li><li>Haloperidol is a centrally acting anti-emetic useful for nausea and vomiting induced by drugs, toxins, and metabolites [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Northern England Clinical Networks, 2016</a>].</li><li>The recommended anti-emetic doses are consistent with specialist palliative care guidelines for the management of nausea and vomiting [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">NHS Scotland, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Lothian Palliative Care Guidelines Group, 2010</a>], palliative care literature from a textbook [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Twycross, 2014</a>], and the British National Formulary [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">BNF 72, 2016</a>].<ul><li>Expert opinion from specialist palliative care guidelines and CKS expert reviewers is that a lower starting dose of haloperidol (that is 0.5 mg instead of 1.5 mg) should be used [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Lothian Palliative Care Guidelines Group, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Northern England Clinical Networks, 2016</a>].</li></ul></li></ul><!-- end field 11ef7941-2a41-4317-9e20-604f27165d59 --><!-- end item d960077e-0630-4df1-ade2-19591c792d3a -->","subChapters":[]}]},{"id":"8b75b009-4445-582a-af49-8e68b7304497","slug":"action-if-first-line-anti-emetic-fails","fullItemName":"Action if first-line anti-emetic fails","depth":3,"htmlHeader":"<!-- begin field 1c94f2d6-2a7f-4c9a-996c-bda6b1895108 --><h3>What should I do if a first-line anti-emetic has not worked?</h3><!-- end field 1c94f2d6-2a7f-4c9a-996c-bda6b1895108 -->","summary":null,"htmlStringContent":"<!-- begin item 1913ff72-1dd3-45cb-b4dc-5d47f04689c5 --><!-- begin field 9ff698f6-dc55-4e98-94d5-2fb44471b51f --><ul><li>If a single first-line anti-emetic does not relieve nausea and vomiting:<ul><li>Optimize the dose of the first-line anti-emetic.</li><li>Consider the need for an alternative route of administration.</li></ul></li><li>If nausea and vomiting persist after two or three doses of optimal first-line anti-emetic:<ul><li>Change to an anti-emetic with a different action, <em>o</em><em><em>r</em> </em>combine anti-emetics with complementary action.<ul><li>Do not combine prokinetics (metoclopramide or domperidone) with antimuscarinics (for example hyoscine, cyclizine, or levomepromazine).</li><li>About one third of people with advanced cancer who experience nausea and vomiting will require more than one anti-emetic to control their nausea and vomiting.</li></ul></li></ul></li><li>Refer to a specialist palliative care team if symptoms remain uncontrolled after 24 hours.</li></ul><!-- end field 9ff698f6-dc55-4e98-94d5-2fb44471b51f --><!-- end item 1913ff72-1dd3-45cb-b4dc-5d47f04689c5 -->","subChapters":[{"id":"aaebd712-5b3c-57cc-9041-ce7bda5f1257","slug":"basis-for-recommendation-e82","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 34025310-5590-40f7-9f61-0158de6a2d3b --><h4>Basis for recommendation</h4><!-- end field 34025310-5590-40f7-9f61-0158de6a2d3b -->","summary":null,"htmlStringContent":"<!-- begin item e82a34e3-fd66-4313-a02c-e5d733b0d8ba --><!-- begin field 6d10045a-f253-40b4-9d85-fcab0a42e54c --><p>These are pragmatic recommendations based on expert opinion from current literature [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Perdue, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Lothian Palliative Care Guidelines Group, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Twycross, 2014</a>] and from CKS expert reviewers.</p><ul><li>Prokinetics should not be used concurrently with drugs with antimuscarinic activity (for example cyclizine and hyoscine) because antimuscarinic drugs competitively block the action of prokinetics [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Lothian Palliative Care Guidelines Group, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">Twycross, 2014</a>].</li><li>CKS are aware that the European Medicines Agency (EMA) has issued advice restricting the use of metoclopramide and domperidone [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">EMA, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">European Medicines Agency, 2014</a>]. Following clarification from the EMA this advice does not apply to to unlicensed uses of metoclopramide (for example palliative care) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/palliative-care-nausea-vomiting/references/\">BNF 72, 2016</a>].</li></ul><!-- end field 6d10045a-f253-40b4-9d85-fcab0a42e54c --><!-- end item e82a34e3-fd66-4313-a02c-e5d733b0d8ba -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}